CAZZAGON, NORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.607
EU - Europa 686
AS - Asia 252
AF - Africa 9
OC - Oceania 4
SA - Sud America 4
Totale 5.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.600
IT - Italia 269
CN - Cina 181
DE - Germania 66
FI - Finlandia 63
GB - Regno Unito 61
SE - Svezia 50
FR - Francia 31
ES - Italia 24
IE - Irlanda 21
UA - Ucraina 21
HK - Hong Kong 20
PL - Polonia 14
IN - India 13
NL - Olanda 12
EG - Egitto 9
JP - Giappone 9
LV - Lettonia 8
RS - Serbia 8
PK - Pakistan 7
RO - Romania 7
NO - Norvegia 6
CY - Cipro 5
VN - Vietnam 5
AR - Argentina 4
AU - Australia 4
CH - Svizzera 4
GR - Grecia 4
MX - Messico 4
BE - Belgio 3
BG - Bulgaria 3
EE - Estonia 3
IQ - Iraq 3
TR - Turchia 3
CA - Canada 2
CZ - Repubblica Ceca 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
ID - Indonesia 1
MN - Mongolia 1
PA - Panama 1
RU - Federazione Russa 1
SG - Singapore 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 5.562
Salva come PNG Salva come JPEG
Città #
Fairfield 919
Woodbridge 495
Houston 397
Ashburn 365
Chandler 363
Seattle 315
Cambridge 311
Ann Arbor 281
Wilmington 251
San Diego 111
Padova 91
Beijing 77
Princeton 77
Medford 76
Jacksonville 62
Des Moines 58
Roxbury 49
Nanjing 31
Helsinki 30
Milan 30
London 25
Boardman 21
Dublin 21
Hong Kong 20
Madrid 17
Rome 16
New York 15
Guangzhou 11
Paris 11
Cairo 9
Frankfurt am Main 9
Shenyang 9
Belgrade 8
Mysiadło 8
Redwood City 8
Riga 8
Stockholm 8
Tianjin 8
Dordives 7
Amsterdam 6
Bucharest 6
Cagliari 6
Falls Church 6
Norwalk 6
Oslo 6
Santa Maria di Sala 6
Brendola 5
Dong Ket 5
Hirakata 5
Hounslow 5
Kyiv 5
Nicosia 5
Palermo 5
Sahiwal 5
Buenos Aires 4
Hebei 4
Jinan 4
Lappeenranta 4
Las Vegas 4
Salerno 4
Verona 4
Aix-en-Provence 3
Baghdad 3
Bergamo 3
Borås 3
Dallas 3
Detroit 3
Hangzhou 3
Jiaxing 3
Kharkiv 3
Mestre 3
Mexico City 3
Nanchang 3
Nole 3
Pont-Sainte-Marie 3
Reggio Emilia 3
Salamanca 3
Shanghai 3
Sofia 3
Sydney 3
Taizhou 3
Tallinn 3
Tampa 3
Tokyo 3
Treviso 3
Vicenza 3
Anyang 2
Athens 2
Brussels 2
Budapest 2
Castel San Pietro Terme 2
Coimbatore 2
Dijon 2
Hyderabad 2
Istanbul 2
Koprivnica 2
Lansing 2
Los Angeles 2
Nashua 2
Ningbo 2
Totale 4.841
Salva come PNG Salva come JPEG
Nome #
UNIGASTRO : Malattie dell' Apparato Digerente . Edizione 2022 - 2025 ( Versione Italiana ) Capitolo: Epatite autoimmune 194
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 159
Extrahepatic autoimmunity in autoimmune liver disease 139
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 136
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 132
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 129
Coronary flow reserve in patients with primary biliary cholangitis 129
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 126
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 121
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 109
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 108
Primary biliary cirrhosis: overlaps with other autoimmune disorders 106
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 103
Rise and fall of HCV-related hepatocellular carcinoma in Italy: a long-term survey from the ITA.LI.CA centres. 100
Diagnostic and Prognostic Role of Scca-IgM Serum Levels in Hepatocellular Carcinoma (Hcc). 100
Molecular targeted therapy in hepatocellular carcinoma: present achievements and future challenges. 99
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 98
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 97
null 93
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 93
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 90
The prognostic role of magnetic resonance imaging in Primary Sclerosing Cholangitis 89
The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis 87
New Organ-Specific Drug Strategies Interfering in Signaling Pathways: Kinase Inhibitors and Other New Developmental Drugs in HCC 87
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 87
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 86
Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response. 85
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 83
New therapies for primary biliary cirrhosis 82
PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 81
Hepatic Stem/Progenitor Cell Activation Differs between Primary Sclerosing and Primary Biliary Cholangitis 80
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 80
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 79
Sleep-wake profiles in patients with primary biliary cirrhosis 78
PBC and related extrahepatic diseases 76
Incidence and risk factors for extra-hepatic malignancies in primary biliary cirrhosis: A comparative study from two European referral centers 74
Pregnancy and Primary Biliary Cirrhosis: A Case-Control Study 74
P.1.158: PEG-INTERFERON ALPHA-2A WITH WEIGHT-BASED RIBAVIRIN DOSES IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES: A PILOT STUDY IN A SINGLE CENTRE 74
Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis 72
A novel HER2-targeted liposomal formulation for reducing the risk of liposome-induced hepatotoxicity 71
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 70
Hepatitis B virus-related hepatocellular carcinoma: primary, secondary, and tertiary prevention. 67
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 66
Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options 64
Proposed therapies in primary biliary cholangitis 63
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from 20-year multicentre experience in Italy 62
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 62
Cholangiocyte senescence in primary sclerosing cholangitis is associated with disease severity and prognosis 60
Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study 58
DIAGNOSTIC AND PROGNOSTIC ROLE OF SCCA-IgM IN HEPATOCELLULAR CARCINOMA (HCC) 56
Recommendations on the use of magnetic resonance imaging for collaborative multicenter studies in PSC 54
Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis 51
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 50
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis 48
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 48
INCIDENCE AND RISK FACTORS FOR EXTRA-HEPATIC MALIGNANCIES (EM) IN PRIMARY BILIARY CIRRHOSIS: A COMPARATIVE STUDY FROM TWO EUROPEAN REFERRAL CENTERS 44
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 43
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 43
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 38
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis 37
METABOLIC SYNDROME INDUCES A MORE RAPID PROGRESSION OF FIBROSIS IN PRIMARY BILIARY CIRRHOSIS IN EARLY STAGE 36
Primary biliary cholangitis: treatment 36
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach 36
Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis 35
Gene expression profile in intrahepatic cholestasis of pregnancy. 34
Rate of Spleen Length Progression Is a Marker of Outcome in Patients With Primary Sclerosing Cholangitis 34
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC 34
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 34
Primary biliary cholangitis: Perception and expectation of illness in Italian patients 32
Pregnancy and primary biliary cirrhosis: A case–control study 28
Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update 28
Pathology of autoimmune hepatitis 28
Gene expression profile in intrahepatic cholestasis of pregnancy. 27
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis 24
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool 23
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 23
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 20
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 18
Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update" 18
Pathology of non-alcoholic fatty liver disease 17
Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury 15
The phenolic compounds tyrosol and hydroxytyrosol counteract liver fibrogenesis via the transcriptional modulation of NADPH oxidases and oxidative stress-related miRNAs 14
Impact on follow-up strategies in patients with primary sclerosing cholangitis 8
The unhealthy lifestyle in primary biliary cholangitis: An enemy to fight 8
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 7
Overlap syndrome 6
Pregnancy and Diseases of the Biliary Tree 5
Greater Transplant-free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls 5
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 4
Protective potential of the gallbladder in primary sclerosing cholangitis 4
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 4
Liver Immunology, Principles and Practice, Third Edition Chapter 24: Primary Biliary Cholangitis: Autoimmune Hepatitis Overlap Syndrome 3
Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in patients with primary sclerosing cholangitis 3
UNIGASTRO: Digestive Diseases. 2022 - 2025 Edition (English Version) Chapter: Autoimmune Hepatitis 3
Non-contrast MR lymphography of the lymphatic system of the liver 2
Maternal liver-related symptoms during pregnancy in primary sclerosing cholangitis 2
Prevalence and significance of antimitochondrial antibodies in autoimmune hepatitis (AIH): Results from a large multicentre study of the International AIH Group 2
Patient-reported quality of care in primary sclerosing cholangitis 1
Primary Sclerosing Cholangitis: Diagnostic Criteria 1
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival 1
Totale 5.733
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.331
article - articoli 21.279
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 691
Totale 44.301
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019414 0 0 0 0 0 0 0 0 0 82 174 158
2019/2020977 122 43 20 109 104 80 96 105 107 102 45 44
2020/20211.092 37 50 168 161 58 33 31 123 122 150 122 37
2021/20221.246 85 82 163 57 69 141 80 96 94 56 87 236
2022/2023895 149 80 13 96 102 153 47 65 102 3 78 7
2023/2024589 25 61 46 54 64 92 123 50 39 35 0 0
Totale 5.733